ANDA 204796, held by Hisun Pharm Hangzhou. Capreomycin Sulfate.
As of Nov 15, 2026, ANDA 204796 (Capreomycin Sulfate), held by Hisun Pharm Hangzhou, was first approved by FDA on Oct 18, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 18, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Capreomycin SulfateEQ 1GM BASE/VIAL ยท injectable;injection | Capreomycin Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
